ABT supply chain intelligence for Abbott Laboratories: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Abbott Laboratories (ABT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| EXAS | Exact Sciences Corp | 92% | Reciprocal relationship from EXAS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from EXAS gra… |
| ENTA | Enanta Pharmaceuticals, Inc. | 90% | Reciprocal relationship from ENTA graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ENTA graph: We entered into a Collaborative Development and License Agreement with Abbott… |
| GRAL | GRAIL, Inc. | 85% | Reciprocal relationship from GRAL graph: Reciprocal relationship from ABT graph: Reciprocal relationship from GRAL graph: Reciprocal relationship from ABT graph: Reciprocal relationship from GRAL gra… |
| ALVO | Alvotech | 72% | Reciprocal relationship from ALVO graph: ion, variation or revocation of an approval. As a result, our business, financial condition and results of operations may be materially harmed. Additionally, … |
| AORT | Artivion, Inc. | 72% | Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a re… |
| BLRX | BioLineRx Ltd. | 72% | Reciprocal relationship from BLRX graph: required to make under our in-licensing agreements is comprised of various components that are paid commensurate with the progressive development and commerci… |
| CODX | Co-Diagnostics, Inc. | 72% | Reciprocal relationship from CODX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from CODX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from CODX gra… |
| CVRX | CVRx, Inc. | 72% | Reciprocal relationship from CVRX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from CVRX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from CVRX gra… |
| DXCM | DexCom, Inc. | 72% | Reciprocal relationship from DXCM graph: Reciprocal relationship from ABT graph: Reciprocal relationship from DXCM graph: we have not built a sales force. To complement our direct sales efforts, we h… |
| FLGT | Fulgent Genetics, Inc. | 72% | Reciprocal relationship from FLGT graph: Reciprocal relationship from ABT graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from ABT graph: Reciprocal relationship from FLGT gra… |
| GCTK | GlucoTrack, Inc. | 72% | Reciprocal relationship from GCTK graph: ability to commercialize our products. 12 The Privacy Provisions of HIPAA In the United States, HIPAA, among other things, protects the privacy and security o… |
| GIFLF | Grifols, S.A. | 72% | Reciprocal relationship from GIFLF graph: ither in late 2025 or early 2026 depending on approvals from regulatory authorities. In several countries, we distribute BLOODchip ® blood group genotyping t… |
| HAE | Haemonetics Corporation | 72% | Reciprocal relationship from HAE graph: Reciprocal relationship from ABT graph: Reciprocal relationship from HAE graph: gies (“Terumo BCT”) and Fresenius SE & Co. KGaA, in particular, have significan… |
| HOLX | Hologic, Inc. | 72% | Reciprocal relationship from HOLX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from HOLX graph: nce services on a time and materials basis to customers that do not have serv… |
| IDXX | IDEXX Laboratories, Inc. | 72% | Reciprocal relationship from IDXX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IDXX graph: y, Inc.; Mindray; and BioNote, Inc. • Water, livestock, poultry, and dairy te… |
| IINN | Inspira Technologies Oxy B.H.N. Ltd. | 72% | Reciprocal relationship from IINN graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IINN graph: em) as well as a disposable unit to be used per patient treatment for both th… |
| ITGR | Integer Holdings Corporation | 72% | Reciprocal relationship from ITGR graph: of units to more significant actions. Our customers include large multi-national medical device OEMs and their subsidiaries. During 2024, three of our custome… |
| IVA | Inventiva S.A. | 72% | Reciprocal relationship from IVA graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IVA graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IVA graph:… |
| MMM | 3M Company | 72% | Reciprocal relationship from MMM graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MMM graph: d Chief Executive Officer, L3Harris Technologies, 2019-2021 Anurag Maheshwari 5… |
| MMSI | Merit Medical Systems, Inc. | 72% | Reciprocal relationship from MMSI graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MMSI graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MMSI gra… |
| MOVE | Corvex Inc. | 72% | Reciprocal relationship from MOVE graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MOVE graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MOVE gra… |
| MTLS | Materialise NV | 72% | Reciprocal relationship from MTLS graph: aborations to enter into other underserved specialty markets. In the medical market, we have entered into collaborations with DePuy Synthes Companies of Johns… |
| NBP | NovaBridge Biosciences | 72% | Reciprocal relationship from NBP graph: rough various potential sources, such as equity and/or debt financings, strategic relationships, potential strategic transactions or out-licensing of our produ… |
| NSPR | InspireMD, Inc. | 72% | Reciprocal relationship from NSPR graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NSPR graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NSPR gra… |
| NSTS | NSTS Bancorp, Inc. | 72% | Reciprocal relationship from NSTS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NSTS graph: retail branch area of Lake County, Illinois. We are also an active originator… |
| NVEC | NVE Corporation | 72% | Reciprocal relationship from NVEC graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NVEC graph: ch 31, 2025, we had more than 50 issued U.S. patents assigned to us. We also … |
| NVS | Novartis AG | 72% | Reciprocal relationship from NVS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NVS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NVS graph:… |
| OBIO | Orchestra BioMed Holdings, Inc. | 72% | Reciprocal relationship from OBIO graph: ve interventional cardiology field include Boston Scientific Corporation, Medtronic plc, Becton Dickinson, Philips N.V., B. Braun, Abbott Laboratories, Cordis… |
| ONCO | Onconetix, Inc. | 72% | Reciprocal relationship from ONCO graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and … |
| PLSE | Pulse Biosciences, Inc. | 72% | Reciprocal relationship from PLSE graph: Reciprocal relationship from ABT graph: Reciprocal relationship from PLSE graph: Reciprocal relationship from ABT graph: Reciprocal relationship from PLSE gra… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-DEFENSE | USGOV-DEPARTMENT-OF-DEFENSE | 95% | USAspending awards from Department of Defense: $50,213,480 across 3 awards. W81XWH19C0071 LABORATORY ASSAY FOR TRAUMATIC BRAIN INJURY; N6264521F0151 CHEMISTRY/IMMUNOASSAY; N6264521F0028 ANALYZER (2),… |
| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | 95% | USAspending awards from Department of Health and Human Services: $70,072,075 across 2 awards. 75A50122C00046 ABBOTT: TO CONDUCT CLINICAL TRAINING AND VALIDATION STUDIES TO SUPPORT A FUTURE FDA MARKET… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | 95% | USAspending awards from Department of Veterans Affairs: $40,732,768 across 5 awards. 36C24924N0401 VISN 9 CHEMISTRY AUTOMATION COST PER RESULTS REPORTABLE; 36C24722F0232 CHEMICAL ANALYZER; 36C24724F0… |
| FLGT | Fulgent Genetics, Inc. | 92% | Reciprocal relationship from FLGT graph: supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair serv… |
| ENTA | Enanta Pharmaceuticals, Inc. | 90% | Reciprocal relationship from ENTA graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ENTA graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ENTA gra… |
| IVA | Inventiva S.A. | 90% | Reciprocal relationship from IVA graph: We have relied on Abbott Laboratories, or Abbott, and Abbott’s partners to have conducted such research and development |
| AORT | Artivion, Inc. | 72% | Reciprocal relationship from AORT graph: Reciprocal relationship from ABT graph: Reciprocal relationship from AORT graph: Reciprocal relationship from ABT graph: Reciprocal relationship from AORT gra… |
| BLRX | BioLineRx Ltd. | 72% | Reciprocal relationship from BLRX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from BLRX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from BLRX gra… |
| CANF | Can-Fite BioPharma Ltd. | 72% | Reciprocal relationship from CANF graph: ient, or API, through a leading Chinese contract research organization, or CRO. The relevant suppliers of our drug products are compliant with both current Go… |
| CVRX | CVRx, Inc. | 72% | Reciprocal relationship from CVRX graph: al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific C… |
| DXCM | DexCom, Inc. | 72% | Reciprocal relationship from DXCM graph: we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several internati… |
| EXAS | Exact Sciences Corp | 72% | , all other includes the long-term assets associated with the defined benefit plans and certain deferred tax assets. 21 Table of Contents Item 2. Management’s Discussion and Analysis of Financial Con… |
| EXAS | Exact Sciences Corp | 72% | Reciprocal relationship from EXAS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from EXAS gra… |
| GCTK | GlucoTrack, Inc. | 72% | Reciprocal relationship from GCTK graph: Reciprocal relationship from ABT graph: Reciprocal relationship from GCTK graph: Reciprocal relationship from ABT graph: Reciprocal relationship from GCTK gra… |
| HOLX | Hologic, Inc. | 72% | Reciprocal relationship from HOLX graph: nce services on a time and materials basis to customers that do not have service contracts. Our Breast Health business generates a majority of our service rev… |
| IINN | Inspira Technologies Oxy B.H.N. Ltd. | 72% | Reciprocal relationship from IINN graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IINN graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IINN gra… |
| ITGR | Integer Holdings Corporation | 72% | Reciprocal relationship from ITGR graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ITGR graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ITGR gra… |
| MMM | 3M Company | 72% | Reciprocal relationship from MMM graph: d Chief Executive Officer, L3Harris Technologies, 2019-2021 Anurag Maheshwari 52 Executive Vice President, Chief Financial Officer 2024 Executive Vice Presiden… |
| MMSI | Merit Medical Systems, Inc. | 72% | Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), Sou… |
| MOVE | Corvex Inc. | 72% | Reciprocal relationship from MOVE graph: design, test, manufacture, exercise quality control over, and document manufacturing of their products; ● labeling and claims regulations, which prohibit the … |
| MTLS | Materialise NV | 72% | Reciprocal relationship from MTLS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MTLS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MTLS gra… |
| NSPR | InspireMD, Inc. | 72% | Reciprocal relationship from NSPR graph: fficiently or implement changes in current products in response to design or regulatory requirements; and ● difficulty identifying and qualifying, and obtaini… |
| NVEC | NVE Corporation | 72% | Reciprocal relationship from NVEC graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NVEC graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NVEC gra… |
| OBIO | Orchestra BioMed Holdings, Inc. | 72% | Reciprocal relationship from OBIO graph: ve interventional cardiology field include Boston Scientific Corporation, Medtronic plc, Becton Dickinson, Philips N.V., B. Braun, Abbott Laboratories, Cordis… |
| ONCO | Onconetix, Inc. | 72% | Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and gre… |
| PLSE | Pulse Biosciences, Inc. | 72% | Reciprocal relationship from PLSE graph: ucted by Professor Stefano Spiezia at the Ospedale del Mare in Naples, Italy, to help us better understand and confirm the mechanism of action and tissue resp… |
| PSNL | Personalis, Inc. | 72% | Reciprocal relationship from PSNL graph: Reciprocal relationship from ABT graph: Reciprocal relationship from PSNL graph: Reciprocal relationship from ABT graph: Reciprocal relationship from PSNL gra… |
| RENXF | RENXF | 72% | Reciprocal relationship from RENXF graph: in Medicare and other healthcare funding and otherwise affect the price of KidneyIntelX and any diagnostic product for which we may obtain regulatory approva… |
| SENS | Senseonics Holdings, Inc. | 72% | Reciprocal relationship from SENS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from SENS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from SENS gra… |
| SVA | Sinovac Biotech Ltd. | 72% | Reciprocal relationship from SVA graph: bined with greater affordability relative to comparable products offered by multinational competitors. Our ability to sustain this positioning also depends on … |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ABT-DEBT | Debt stack $34.0B | 90% | Market cache reports total debt of $34.0B. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| ABT-OWNER-CAPITAL-RESEARCH-GLOBAL-INVESTORS | Capital Research Global Investors | 95% | 13F/ownership overlay lists Capital Research Global Investors; shares held 49,775,362; value $5.11T; as of 2026-03-31. |
| ABT-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC | VANGUARD CAPITAL MANAGEMENT LLC | 95% | 13F/ownership overlay lists VANGUARD CAPITAL MANAGEMENT LLC; shares held 225,899,866; ownership 12.97%; value $23.19T; as of 2026-03-31. |
| ABT-OWNER-STATE-STREET-CORP | STATE STREET CORP | 95% | 13F/ownership overlay lists STATE STREET CORP; shares held 79,575,468; value $8.17T; as of 2026-03-31. |
| ABT-OWNER-BLACKROCK-INC | BlackRock, Inc. | 95% | 13F/ownership overlay lists BlackRock, Inc.; shares held 145,793,958; value $14.97T; as of 2026-03-31. |
| ABT-OWNER-BARCLAYS-PLC | BARCLAYS PLC | 95% | 13F/ownership overlay lists BARCLAYS PLC; shares held 49,755,430; value $5.61T; as of 2026-03-31. |
| ABT-OWNER-MORGAN-STANLEY | MORGAN STANLEY | 95% | 13F/ownership overlay lists MORGAN STANLEY; shares held 105,463,925; value $12.87T; as of 2026-03-31. |
| ABT-OWNER-DZ-BANK-AG-DEUTSCHE-ZENTRAL-GENOSSENSCHA | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 95% | 13F/ownership overlay lists DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main; shares held 64,655,123; value $7.20T; as of 2026-03-31. |
| ABT-OWNER-VANGUARD-PORTFOLIO-MANAGEMENT-LLC | VANGUARD PORTFOLIO MANAGEMENT LLC | 95% | 13F/ownership overlay lists VANGUARD PORTFOLIO MANAGEMENT LLC; shares held 47,944,891; value $4.92T; as of 2026-03-31. |
| ABT-OWNER-CHARLES-SCHWAB-INVESTMENT-MANAGEMENT-INC | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 95% | 13F/ownership overlay lists CHARLES SCHWAB INVESTMENT MANAGEMENT INC; shares held 45,500,055; value $4.67T; as of 2026-03-31. |
| ABT-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | GEODE CAPITAL MANAGEMENT, LLC | 95% | 13F/ownership overlay lists GEODE CAPITAL MANAGEMENT, LLC; shares held 39,148,795; value $4.00T; as of 2026-03-31. |
| ABT | Abbott Laboratories | 82% | Roman Michael F | Director | option_exercise | 367 shares |
| ABT | Abbott Laboratories | 82% | Stratton John G | Director | option_exercise | 382 shares |
| ABT | Abbott Laboratories | 82% | Orville Jacob A | Senior Vice President | option_exercise | 13255 shares |
| ABT | Abbott Laboratories | 82% | Jacob A. Orville | Officer |
| ABT | Abbott Laboratories | 82% | Orville Jacob A | Senior Vice President | option_exercise | 13255 shares |
| ABT | Abbott Laboratories | 82% | Boudreau Philip P | EVP AND CFO | sell | 7441 shares |
| ABT | Abbott Laboratories | 82% | Shroff Eric | Senior Vice President | sell | 709 shares |
| ABT | Abbott Laboratories | 82% | Scoggins Christopher J | EXECUTIVE VICE PRESIDENT | sell | 4997 shares |
| ABT | Abbott Laboratories | 82% | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | sell | 885 shares |
| ABT | Abbott Laboratories | 82% | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | sell | 1144 shares |
| ABT | Abbott Laboratories | 82% | Moreland Mary K | EXECUTIVE VICE PRESIDENT | sell | 613 shares |
| ABT | Abbott Laboratories | 82% | MCCOY JOHN A. JR. | VICE PRESIDENT AND CONTROLLER | sell | 585 shares |
| ABT | Abbott Laboratories | 82% | Ford Robert B | CHAIRMAN AND CEO | sell | 30308 shares |
| ABT | Abbott Laboratories | 82% | Earnhardt Lisa D | EVP AND GROUP PRESIDENT | sell | 8577 shares |
| ABT | Abbott Laboratories | 82% | Cushman Elizabeth C. | EVP, GC AND SECRETARY | sell | 263 shares |
| ABT | Abbott Laboratories | 82% | Boudreau Philip P | EVP AND CFO | sell | 7441 shares |
| ABT | Abbott Laboratories | 82% | Cushman Elizabeth C. | EVP, GC AND SECRETARY | sell | 263 shares |
| ABT | Abbott Laboratories | 82% | Earnhardt Lisa D | EVP AND GROUP PRESIDENT | sell | 8577 shares |
| ABT | Abbott Laboratories | 82% | Ford Robert B | CHAIRMAN AND CEO | sell | 30308 shares |
| ABT | Abbott Laboratories | 82% | MCCOY JOHN A. JR. | VICE PRESIDENT AND CONTROLLER | sell | 585 shares |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| CPMV | Mosaic ImmunoEngineering, Inc. | 100.00 | 2 | |
| HLNCF | Haleon plc | 100.00 | 2 | |
| CTMX | CytomX Therapeutics, Inc. | 100.00 | 2 | |
| SDGR | Schrödinger, Inc. | 100.00 | 2 | |
| ELVN | Enliven Therapeutics, Inc. | 100.00 | 2 | |
| COLL | Collegium Pharmaceutical, Inc. | 100.00 | 2 | |
| BBNX | Beta Bionics, Inc. | 100.00 | 1 | ['supplier'] |
| GCTK | GlucoTrack, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| BLRX | BioLineRx Ltd. | 100.00 | 1 | ['customer', 'supplier'] |
| HAE | Haemonetics Corporation | 100.00 | 1 | ['supplier'] |
| ANL | Adlai Nortye Ltd. | 100.00 | 2 | |
| SLGL | Sol-Gel Technologies Ltd. | 100.00 | 2 | |
| CODX | Co-Diagnostics, Inc. | 100.00 | 1 | ['supplier'] |
| BIOA | BioAge Labs, Inc. | 100.00 | 2 | |
| AORT | Artivion, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| CVRX | CVRx, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| GRAL | GRAIL, Inc. | 100.00 | 1 | ['supplier'] |
| CTNM | Contineum Therapeutics, Inc. | 100.00 | 2 | |
| ALVO | Alvotech | 100.00 | 1 | ['supplier'] |
| DXCM | DexCom, Inc. | 100.00 | 1 | ['customer', 'supplier'] |